Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
2003 2
2005 1
2011 1
2012 1
2013 2
2014 2
2015 4
2016 1
2017 2
2024 1

Text availability

Article attribute

Article type

Publication date

Search Results

16 results

Results by year

Filters applied: . Clear all
The following term was not found in PubMed: thiatriazol-5-ylsulfanyl
Page 1
6-Chloro-N-(pyridin-4-ylmeth-yl)pyridine-3-sulfonamide.
Suchetan PA, Mohan RN, Vijithkumar, Palakshamurthy BS, Sreenivasa S. Suchetan PA, et al. Acta Crystallogr Sect E Struct Rep Online. 2013 Nov 13;69(Pt 12):o1765. doi: 10.1107/S1600536813030523. eCollection 2013 Nov 13. Acta Crystallogr Sect E Struct Rep Online. 2013. PMID: 24454215 Free PMC article.
Syntheses of Novel 4-Substituted N-(5-amino-1H-1,2,4-triazol-3-yl)pyridine-3-sulfonamide Derivatives with Potential Antifungal Activity.
Szafrański K, Sławiński J, Kędzia A, Kwapisz E. Szafrański K, et al. Molecules. 2017 Nov 7;22(11):1926. doi: 10.3390/molecules22111926. Molecules. 2017. PMID: 29112162 Free PMC article.
Therefore, we have undertaken the synthesis of compounds comprising a pyridine-3-sulfonamide scaffold and known antifungally active 1,2,4-triazole substituents. Thus a series of novel 4-substituted N-(5-amino-1H-1,2,4-triazol-3-yl)pyridin …
Therefore, we have undertaken the synthesis of compounds comprising a pyridine-3-sulfonamide scaffold and known antifun …
Inhibition of cancer cell invasion by new ((3,4-dihydroxy benzylidene)hydrazinyl)pyridine-3-sulfonamide analogs.
Kang SM, Nam KY, Jung SY, Song KH, Kho S, No KT, Choi HK, Song JY. Kang SM, et al. Bioorg Med Chem Lett. 2016 Feb 15;26(4):1322-8. doi: 10.1016/j.bmcl.2015.12.093. Epub 2015 Dec 29. Bioorg Med Chem Lett. 2016. PMID: 26810259
Among the synthesized compounds, (E)-N-(3-chlorophenyl)-6-(2-(3,4-dihydroxy benzylidene)hydrazinyl)pyridine-3-sulfonamide (3d) and (E)-N-benzyl-6-(2-(3,4-dihydroxy benzylidene)hydrazinyl)-N-methylpyridine-3-sulfonamide (3f) significantly inhibit …
Among the synthesized compounds, (E)-N-(3-chlorophenyl)-6-(2-(3,4-dihydroxy benzylidene)hydrazinyl)pyridine-3-sulfon …
Synthesis of Novel 1-(4-Substituted pyridine-3-sulfonyl)-3-phenylureas with Potential Anticancer Activity.
Szafrański K, Sławiński J. Szafrański K, et al. Molecules. 2015 Jul 1;20(7):12029-44. doi: 10.3390/molecules200712029. Molecules. 2015. PMID: 26140437 Free PMC article.
A series of novel 4-substituted-N-(phenylcarbamoyl)-3-pyridinesulfonamides 11-27 have been synthesized by the reaction of 4-substituted pyridine-3-sulfonamides 2-10 with the appropriate aryl isocyanates in presence of potassium carbonate. ...National Cancer Institut …
A series of novel 4-substituted-N-(phenylcarbamoyl)-3-pyridinesulfonamides 11-27 have been synthesized by the reaction of 4-su …
Carbonic anhydrase inhibitors. Synthesis of heterocyclic 4-substituted pyridine-3-sulfonamide derivatives and their inhibition of the human cytosolic isozymes I and II and transmembrane tumor-associated isozymes IX and XII.
Sławiński J, Szafrański K, Vullo D, Supuran CT. Sławiński J, et al. Eur J Med Chem. 2013 Nov;69:701-10. doi: 10.1016/j.ejmech.2013.09.027. Epub 2013 Sep 20. Eur J Med Chem. 2013. PMID: 24095761
A series of novel heterocyclic 4-substituted pyridine-3-sulfonamides 2-13, 15-20 have been synthesized and investigated as inhibitors of four isoforms of zinc enzyme carbonic anhydrase (CA.EC 4.2.1.1), that is the cytosolic CA I and II, and tumor-associated isozymes …
A series of novel heterocyclic 4-substituted pyridine-3-sulfonamides 2-13, 15-20 have been synthesized and investigated as inhibitors …
Selective I(Kur) Inhibitors for the Potential Treatment of Atrial Fibrillation: Optimization of the Phenyl Quinazoline Series Leading to Clinical Candidate 5-[5-Phenyl-4-(pyridin-2-ylmethylamino)quinazolin-2-yl]pyridine-3-sulfonamide.
Gunaga P, Lloyd J, Mummadi S, Banerjee A, Dhondi NK, Hennan J, Subray V, Jayaram R, Rajugowda N, Umamaheshwar Reddy K, Kumaraguru D, Mandal U, Beldona D, Adisechen AK, Yadav N, Warrier J, Johnson JA, Sale H, Putlur SP, Saxena A, Chimalakonda A, Mandlekar S, Conder M, Xing D, Gupta AK, Gupta A, Rampulla R, Mathur A, Levesque P, Wexler RR, Finlay HJ. Gunaga P, et al. J Med Chem. 2017 May 11;60(9):3795-3803. doi: 10.1021/acs.jmedchem.6b01889. Epub 2017 Apr 28. J Med Chem. 2017. PMID: 28418664
We have recently disclosed 5-phenyl-N-(pyridin-2-ylmethyl)-2-(pyrimidin-5-yl)quinazolin-4-amine 1 as a potent I(Kur) current blocker with selectivity versus hERG, Na and Ca channels, and an acceptable preclinical PK profile. ...In an effort to reduce the level of brain pen …
We have recently disclosed 5-phenyl-N-(pyridin-2-ylmethyl)-2-(pyrimidin-5-yl)quinazolin-4-amine 1 as a potent I(Kur) current blocker …
Synthesis, Crystal Structure, Absolute Configuration and Antitumor Activity of the Enantiomers of 5-Bromo-2-chloro-N-(1-phenylethyl)pyridine-3-sulfonamide.
Zhou Z, Li L, Yan N, Du L, Sun C, Sun T. Zhou Z, et al. Molecules. 2015 Nov 24;20(11):20926-38. doi: 10.3390/molecules201119740. Molecules. 2015. PMID: 26610458 Free PMC article.
Pyridinesulfonamide is an important fragment which has a wide range of applications in novel drugs. R- and S-isomers of 5-bromo-2-chloro-N-(1-phenylethyl)pyridine-3-sulfonamide have been synthesized, and the stereostructures have been researched. ...
Pyridinesulfonamide is an important fragment which has a wide range of applications in novel drugs. R- and S-isomers of 5-bromo-2-chloro-N-( …
Supramolecular structures of three isomeric 4-(methylphenylamino)pyridine-3-sulfonamides.
Kosutić Hulita N, Danilovski A, Filić D, Marinković M, Mestrović E, Dumić M. Kosutić Hulita N, et al. Acta Crystallogr C. 2005 Nov;61(Pt 11):o648-51. doi: 10.1107/S0108270105031902. Epub 2005 Oct 22. Acta Crystallogr C. 2005. PMID: 16272600
The structures of the three title isomers, namely 4-(2-methylanilino)pyridine-3-sulfonamide, (I), 4-(3-methylanilino)pyridine-3-sulfonamide, (II), and 4-(4-methylanilino)pyridine-3-sulfonamide …
The structures of the three title isomers, namely 4-(2-methylanilino)pyridine-3-sulfonamide, (I), 4-(3-me …
Pyridinesulfonylureas and pyridinesulfonamides as selective bombesin receptor subtype-3 (BRS-3) agonists.
Lo MM, Chobanian HR, Palyha O, Kan Y, Kelly TM, Guan XM, Reitman ML, Dragovic J, Lyons KA, Nargund RP, Lin LS. Lo MM, et al. Bioorg Med Chem Lett. 2011 Apr 1;21(7):2040-3. doi: 10.1016/j.bmcl.2011.02.011. Epub 2011 Feb 25. Bioorg Med Chem Lett. 2011. PMID: 21354793
BRS-3 is implicated in the development of obesity and diabetes. We report here small-molecule agonists that are based on a 4-(alkylamino)pyridine-3-sulfonamide core. We describe the discovery of 2a, which has mid-nanomolar potency, selectivity for huma …
BRS-3 is implicated in the development of obesity and diabetes. We report here small-molecule agonists that are based on a 4-(alkylam …
16 results